Used in peptide synthesis as a chiral building block to introduce steric hindrance and enhance metabolic stability in bioactive peptides. The α-methyl group restricts conformational flexibility, making it valuable in designing peptidomimetics and enzyme inhibitors. The Fmoc group allows for solid-phase synthesis under mild basic conditions, compatible with standard protocols in automated peptide synthesis. Commonly applied in pharmaceutical research for developing therapeutic peptides with improved pharmacokinetic profiles.